Evidence map›Paper›PMID 25361805›Full record

ArticleJournal of the National Comprehensive Cancer Network : JNCCN2014

Socioeconomic and clinical factors are key to uncovering disparity in accrual onto therapeutic trials for breast cancer.

Carolyn E Behrendt, Arti Hurria, Lusine Tumyan, Joyce C Niland, Joanne E Mortimer

Abstract read
In one paragraph

Article in Journal of the National Comprehensive Cancer Network : JNCCN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Breast Cancer Disparities and the COVID-19 Pandemic.Current breast cancer reports · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carolyn E BehrendtFrom the Departments of Information Sciences, Medical Oncology, and Diagnostic Radiology, City of Hope Comprehensive Cancer Center, Duarte, California.
Arti HurriaFrom the Departments of Information Sciences, Medical Oncology, and Diagnostic Radiology, City of Hope Comprehensive Cancer Center, Duarte, California.
Lusine TumyanFrom the Departments of Information Sciences, Medical Oncology, and Diagnostic Radiology, City of Hope Comprehensive Cancer Center, Duarte, California.
Joyce C NilandFrom the Departments of Information Sciences, Medical Oncology, and Diagnostic Radiology, City of Hope Comprehensive Cancer Center, Duarte, California.
Joanne E MortimerFrom the Departments of Information Sciences, Medical Oncology, and Diagnostic Radiology, City of Hope Comprehensive Cancer Center, Duarte, California.

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
NCI NIH HHS P30 CA033572NCI NIH HHS P30CA033572
6 · The paper itself

Abstract

To monitor and address disparity in accrual, patient participation in cancer clinical trials is routinely summarized by race/ethnicity. To investigate whether confounding obscures racial/ethnic disparity in participation, all women with breast cancer treated by medical oncologists at City of Hope Comprehensive Cancer Center from 2004 through 2009 were classified by birthplace and self-reported race/ethnicity, and followed for accrual onto therapeutic trials through 2010. Undetectable on univariate analysis, significantly reduced participation by subjects of African, Asian, Eastern European, Latin American, and Middle Eastern ancestries was revealed after accounting for age, socioeconomic factors, tumor and oncologist characteristics, and intrapractice clustering of patients.

Indexed as

Breast NeoplasmsClinical Trials as TopicEthnicityFemaleHumansPatient ParticipationSocioeconomic Factors

Identifiers

PMID25361805
PMCPMC4601901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.